Pharmacological and clinical trial data on a novel phosphate-binding polymer (sevelamer hydrochloride), a medicine for hyperphosphatemia in hemodialysis patients.-Reference-Cited by-同舟云学术

Pharmacological and clinical trial data on a novel phosphate-binding polymer (sevelamer hydrochloride), a medicine for hyperphosphatemia in hemodialysis patients.

Published:2003 Issue:5 Volume:122 Page:443-453
ISSN:0015-5691
Container-title:Folia Pharmacologica Japonica
language:ja
Short-container-title:Folia Pharmacol. Jpn.

Author:

NAGANO Nobuo,FUKUSHIMA Naoshi

Publisher

Japanese Pharmacological Society

Subject

Pharmacology

Reference39 articles.

1. Homeostasis of Phosphate Revisited

2. 2) Suki WN, Lederer ED, Rouse D. Renal transport of calcium, magnesium, and phosphate. In: Brenner BM, editor. The Kidney. 6th ed. Philadelphia: WB Saunders Co; 2000. p. 520-574.

3. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management

4. Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of fatty acids on the phosphate binding of TRK-390, a novel, highly selective phosphate-binding polymer;European Journal of Pharmacology;2013-08

2. Effects of Switch From Sevelamer Hydrochloride to Lanthanum Carbonate on Serum K and Bone Metabolic Turnover;Therapeutic Apheresis and Dialysis;2013-04

3. Utilization of titanium oxide-like compound as an inorganic phosphate adsorbent for the control of serum phosphate level in chronic renal failure;The Journal of Medical Investigation;2010

4. Vitamin D;Nutrition in Clinical Practice;2009-10

5. Pharmacological and clinical profiles of calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients on dialysis (cinacalcet hydrochloride, REGPARA®);Folia Pharmacologica Japonica;2008